毒蕈碱乙酰胆碱受体
变构调节
乙酰胆碱
变构调节剂
化学
乙酰胆碱受体
兴奋剂
药理学
体外
受体
胆碱能的
生物物理学
神经科学
立体化学
生物化学
医学
生物
作者
Xiaoyun Deng,Akiko Hatori,Zhen Chen,Katsushi Kumata,Tuo Shao,Xiaofei Zhang,Tomoteru Yamasaki,Kuan Hu,Qingzhen Yu,Longle Ma,Gangqiang Wang,Lu Wang,Yihan Shao,Lee Josephson,Shaofa Sun,Ming‐Rong Zhang,Steven H. Liang
出处
期刊:ChemMedChem
[Wiley]
日期:2018-12-27
卷期号:14 (3): 303-309
被引量:11
标识
DOI:10.1002/cmdc.201800710
摘要
Abstract Muscarinic acetylcholine receptors (mAChRs) have five distinct subunits (M 1 –M 5 ) and are involved in the action of the neurotransmitter acetylcholine in the central and peripheral nervous system. Attributed to the promising clinical efficacy of xanomeline, an M 1 /M 4 ‐preferring agonist, in patients of schizophrenia and Alzheimer's disease, M 1 ‐ or M 4 ‐selective mAChR modulators have been developed that target the topographically distinct allosteric sites. Herein we report the synthesis and preliminary evaluation of 11 C‐labeled positron emission tomography (PET) ligands based on a validated M 4 R positive allosteric modulator VU0467485 (AZ13713945) to facilitate drug discovery. [ 11 C]VU0467485 and two other ligands were prepared in high radiochemical yields (>30 %, decay‐corrected) with high radiochemical purity (>99 %) and high molar activity (>74 GBq μmol −1 ). In vitro autoradiography studies indicated that these three ligands possess moderate‐to‐high in vitro specific binding to M 4 R. Nevertheless, further physiochemical property optimization is necessary to overcome the challenges associated with limited brain permeability.
科研通智能强力驱动
Strongly Powered by AbleSci AI